Genomics & Gene Editing
Genomics reads the genetic code and gene editing rewrites it, which can turn an inherited disease from a lifelong condition into a single treatment. Sequencing cost has fallen far enough to make study at population scale routine.
199 stocks
| # | Name | Holding | Trade Value |
Theme Stocks |
% of Portfolio | Status | |
|---|---|---|---|---|---|---|---|
| 26 |
BlackRock Group
London,
United Kingdom
| $1.77B | -$127M | 35 | 0.89% | Reduced |
|
| 27 |
TS
Third Security
Radford,
Virginia
| $1.75B | +$3.31M | 2 | 81.34% | Increased |
|
| 28 |
Invesco
Atlanta,
Georgia
| $1.73B | -$98.2M | 25 | 0.59% | Reduced |
|
| 29 |
Janus Henderson Investors US
Denver,
Colorado
| $1.55B | +$164M | 16 | 1.31% | Increased |
|
| 30 |
Ameriprise
Minneapolis,
Minnesota
| $1.42B | -$16.2M | 20 | 0.8% | Reduced |
|
| 31 |
UBS Group
Zurich,
Switzerland
| $1.3B | -$29.8M | 62 | 0.78% | Reduced |
|
| 32 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| $1.19B | -$9.12M | 55 | 0.84% | Reduced |
|
| 33 |
UBS AM
Chicago,
Illinois
| $1.19B | -$79.8M | 25 | 1.28% | Reduced |
|
| 34 |
Dimensional Fund Advisors
Austin,
Texas
| $1.19B | +$38.2M | 27 | 0.64% | Increased |
|
| 35 |
QF
QVT Financial
New York
| $1.18B | +$1.19B | 8 | 44.35% | Increased |
|
| 36 |
TIAA CREF Investment Management
New York
| $1.16B | -$108M | 40 | 0.73% | Reduced |
|
| 37 |
Winslow Capital Management
Minneapolis,
Minnesota
| $1.05B | +$63.5M | 3 | 4.38% | Increased |
|
| 38 |
BlackRock Advisors
Wilmington,
Delaware
| $1.05B | +$48.6M | 49 | 1.08% | Increased |
|
| 39 |
ClearBridge Investments
New York
| $1B | +$9.65M | 13 | 1.13% | Increased |
|
| 40 |
Loomis, Sayles & Company
Boston,
Massachusetts
| $949M | +$455M | 5 | 2.4% | Increased |
|
| 41 |
Select Equity Group
New York
| $946M | -$45.1M | 5 | 8.17% | Reduced |
|
| 42 |
Pictet Asset Management (UK)
London,
United Kingdom
| $928M | -$52.5M | 12 | 3.49% | Reduced |
|
| 43 |
Parnassus Investments
San Francisco,
California
| $921M | -$31.3M | 2 | 5.03% | Reduced |
|
| 44 |
Edgewood Management
Greenwich,
Connecticut
| $904M | +$17.7M | 2 | 5.94% | Increased |
|
| 45 |
OrbiMed
New York
| $889M | -$216M | 20 | 10.12% | Reduced |
|
| 46 |
BlackRock Investment Management
Wilmington,
Delaware
| $884M | +$32.5M | 54 | 1.09% | Increased |
|
| 47 |
Legal & General Group
London,
United Kingdom
| $841M | -$67.5M | 35 | 0.85% | Reduced |
|
| 48 |
Putnam Investments
Boston,
Massachusetts
| $803M | +$51.8M | 18 | 1.93% | Increased |
|
| 49 |
Charles Schwab
San Francisco,
California
| $757M | -$18.1M | 40 | 0.89% | Reduced |
|
| 50 |
Brown Brothers Harriman & Co
New York
| $749M | -$22.5M | 9 | 3.97% | Reduced |
|